Command Palette

Search for a command to run...

ALBERTDAVD
803(+0.07%)
1W: +2.71%

Albert David Peer Comparison

Snapshot Summary

Albert David Ltd. is currently positioned in a challenging space with stagnant growth, but comparisons with its peers reveal several outperformers, especially in profitability and growth metrics. Companies like Mankind Pharma and Dr. Reddy's show strong potential. While Albert David has low valuations, it lacks growth and profitability metrics, making it less attractive.

  • Albert David Ltd. shows zero revenue growth and profitability metrics, indicating stagnation.
  • Mankind Pharma and Dr. Reddy's Laboratories lead in profitability and growth metrics among peers.
  • Sun Pharma appears overvalued with a high PE ratio despite decent growth.
  • Mankind Pharma Ltd.: Strong revenue growth (18.12% YoY) and high profitability metrics (ROE: 23.15%).
  • Dr. Reddy's Laboratories Ltd.: High ROE (21.76%) and solid growth metrics (EPS: 68.07).
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ALBERTDAVD₹814.70₹464.96Cr27.03--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.